Pharmaceutical interventions vs placebo
Activities of daily living · emotionalism after stroke
1 finding from 1 review
- no estimate extracted1 study · 28 participantsLow
Findings
What do systematic reviews say?
4,756 questions · 13,493 findings · 1,305 reviews · Headline outcomes only
No studies found 2,594 · 19.2%GRADE not reported 728 · 5.4%Very low 2,868 · 21.3%Low 3,777 · 28%Moderate 2,620 · 19.4%High 906 · 6.7%
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Pharmaceutical interventions vs placebo
Adverse events: 1. death: at end of treatment · emotionalism after stroke
Pharmaceutical interventions showed no clear difference in adverse events: 1. death: at end of treatment compared with placebo (moderate certainty).
1 finding from 1 review
- RR 0.59 [0.08, 4.5]6 studies · 172 participantsModerate
NSAIDs vs placebo or active control
Visual improvement at end of treatment, as defined by two or more Snellen lines · participants with acute CME (< 4 months) following cataract surgery
It is very uncertain whether NSAID changes visual improvement at end of treatment, as defined by two or more… compared with placebo or active control (very low certainty).
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyRR 2 [0.46, 8.76]1 study · 22 participantsVery low
NSAIDs vs placebo
Improvement in central macular thickness on OCT · participants with chronic CME (≥ 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
NSAIDs vs placebo
Improved contrast sensitivity · participants with chronic CME (≥ 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
NSAIDs vs placebo
QoL · participants with chronic CME (≥ 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
NSAIDs vs placebo or active control
Persistence of visual improvement one month after discontinuation of treatment · participants with acute CME (< 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
NSAIDs vs placebo or active control
Improvement in leakage on FFA Â · participants with acute CME (< 4 months) following cataract surgery
It is very uncertain whether NSAID changes improvement in leakage on FFA Â compared with placebo or active control (very low certainty).
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyRR 1.11 [0.45, 2.75]1 study · 17 participantsVery low
NSAIDs vs placebo or active control
Improvement in central macular thickness on OCT · participants with acute CME (< 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
NSAIDs vs placebo or active control
Improved contrast sensitivity · participants with acute CME (< 4 months) following cataract surgery
It is very uncertain whether NSAID changes improved contrast sensitivity  compared with placebo or active control (very low certainty).
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyRR 1.11 [0.45, 2.75]1 study · 17 participantsVery low
NSAIDs vs placebo or active control
QoL · participants with acute CME (< 4 months) following cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
NSAIDs vs placebo
Visual improvement at end of treatment, as defined by two or more Snellen lines · participants with chronic CME (≥ 4 months) following cataract surgery
It is very uncertain whether NSAID changes visual improvement at end of treatment, as defined by two or more… compared with placebo (very low certainty).
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyRR 0.72 [0.3, 1.73]2 studies · 34 participantsVery low
NSAIDs vs placebo
Persistence of visual improvement one month after discontinuation of treatment · participants with chronic CME (≥ 4 months) following cataract surgery
It is very uncertain whether NSAID changes persistence of visual improvement one month after discontinuation of… compared with placebo (very low certainty).
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyRR 1.17 [0.44, 3.07]2 studies · 46 participantsVery low
NSAIDs vs placebo
Improvement in leakage on FFA Â · participants with chronic CME (≥ 4 months) following cataract surgery
It is very uncertain whether NSAID changes improvement in leakage on FFA Â compared with placebo (very low certainty).
1 finding from 1 review
- Non‐steroidal anti‐inflammatory agents for treating cystoid macular edema following cataract surgery 2022 · Cochrane Headline outcomes onlyRR 1.93 [0.62, 6.02]2 studies · 40 participantsVery low
Music therapy vs placebo or usual care
Global improvement · Individuals with autism spectrum disorder
Music therapy probably leads to higher global improvement compared with placebo therapy or standard care (moderate certainty).
1 finding from 1 review
- RR 1.22 [1.06, 1.4]8 studies · 583 participantsModerate
Music therapy vs placebo or usual care
Social interaction · Individuals with autism spectrum disorder
1 finding from 1 review
- no estimate extracted12 studies · 603 participantsLow
Music therapy vs placebo or usual care
Non‐verbal communication · Individuals with autism spectrum disorder
1 finding from 1 review
- no estimate extracted7 studies · 192 participantsLow
Music therapy vs placebo or usual care
Verbal communication · Individuals with autism spectrum disorder
1 finding from 1 review
- no estimate extracted8 studies · 276 participantsVery low
Music therapy vs placebo or usual care
Quality of life · Individuals with autism spectrum disorder
1 finding from 1 review
- no estimate extracted3 studies · 340 participantsModerate
Music therapy vs placebo or usual care
Autism symptom severity Measured by: parent‐reported autism symptoms on standardised autism screening and diagnostic instruments (lower scores indicate less severe autism symptoms) · Individuals with autism spectrum disorder
1 finding from 1 review
- no estimate extracted9 studies · 575 participantsModerate